{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:10:31Z","timestamp":1777893031745,"version":"3.51.4"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.beha.2023.101440","type":"journal-article","created":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T09:30:38Z","timestamp":1673775038000},"page":"101440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diagnosis and management of rare paediatric Non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Ana C.","family":"Xavier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-6898","authenticated-orcid":false,"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib1","first-page":"83","article-title":"Childhood and adolescent cancer statistics","volume":"64","author":"Ward","year":"2014","journal-title":"Ca - Cancer J Clin"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28416","article-title":"Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma","volume":"67","author":"Attarbaschi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjh.14074","article-title":"Adolescent and young adult non-Hodgkin lymphoma","volume":"173","author":"Hochberg","year":"2016","journal-title":"Br J Haematol"},{"issue":"27","key":"10.1016\/j.beha.2023.101440_bib4","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","article-title":"Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead","volume":"33","author":"Minard-Colin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5858\/133.1.142","article-title":"Pediatric follicular lymphoma: a rare clinicopathologic entity","volume":"133","author":"Agrawal","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/M7YV-V8V2-A5VA-J1Y4","article-title":"Follicular hodgkin lymphoma: a histopathologic study","volume":"117","author":"Kansal","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.beha.2023.101440_bib10","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.beha.2023.101440_bib12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2141.1998.00941.x","article-title":"Conservative management of follicular non-Hodgkin's lymphoma in childhood","volume":"103","author":"Atra","year":"1998","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib14","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00277-013-1785-2","article-title":"Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a \"Watch and wait\" strategy after complete resection","volume":"92","author":"Attarbaschi","year":"2013","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pbc.23110","article-title":"Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma","volume":"57","author":"Kumar","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"10.1016\/j.beha.2023.101440_bib16","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised international pediatric non-hodgkin lymphoma staging system","volume":"33","author":"Rosolen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib17","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V99.6.1959","article-title":"Clinicopathologic analysis of follicular lymphoma occurring in children","volume":"99","author":"Lorsbach","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib20","first-page":"308","article-title":"Follicular lymphomas in pediatric patients","volume":"3","author":"Pinto","year":"1990","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/bjh.15194","article-title":"Incidence and outcomes of rare paediatric non-hodgkin lymphomas","volume":"184","author":"Sorge","year":"2019","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"10.1016\/j.beha.2023.101440_bib22","first-page":"S98","article-title":"Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia","volume":"122","author":"Swerdlow","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2023.101440_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hon.2585","article-title":"Rare mature B-cell lymphomas in children and adolescents","volume":"37","author":"Woessmann","year":"2019","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pbc.26236","article-title":"IFR4\/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10","volume":"64","author":"Chen","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib25","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27770","article-title":"IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials","volume":"66","author":"Chisholm","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2011.08969.x","article-title":"Guidelines on the investigation and management of follicular lymphoma","volume":"156","author":"McNamara","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pbc.23152","article-title":"Pediatric indolent lymphoma--would less be better?","volume":"57","author":"Perkins","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101440_bib33","series-title":"Rituximab and FAB\/LMB 96 chemotherapy in children with Stage III\/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report","author":"Goldman","year":"2012"},{"issue":"23","key":"10.1016\/j.beha.2023.101440_bib34","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-hodgkin's lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cncr.20382","article-title":"Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)","volume":"101","author":"Pillon","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1309\/4EJ8T3R2ERKQ61WH","article-title":"Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations","volume":"121","author":"Kussick","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.beha.2023.101440_bib39","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","article-title":"Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma","volume":"26","author":"Marcus","year":"2008","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.beha.2023.101440_bib40","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib41","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2011.10.018","article-title":"Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report","volume":"48","author":"Shankar","year":"2012","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib42","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/pbc.25881","article-title":"Rare pediatric non-hodgkin lymphomas: a report from children's Oncology group study ANHL 04B1","volume":"63","author":"O'Suoji","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib44","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bjd.14932","article-title":"Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?","volume":"176","author":"Amitay-Laish","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib45","first-page":"369","article-title":"[Paediatric nodal marginal zone lymphoma: a clinicopathological study of seven cases]","volume":"48","author":"Bai","year":"2019","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pbc.20575","article-title":"MALT lymphoma in children: a report from the NHL-BFM Study Group","volume":"47","author":"Claviez","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.reuma.2017.01.015","article-title":"Extranodal marginal zone B cell lymphoma: an unexpected complication in children with Sjogren's syndrome","volume":"14","author":"Collado","year":"2018","journal-title":"Reumatol Cl\u00ednica"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib48","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/MPH.0b013e3182826656","article-title":"Pediatric extranodal marginal zone B-cell lymphoma presenting as amyloidosis in minor salivary glands: a case report and review of the literature","volume":"35","author":"Gabali","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ped.13188","article-title":"Pediatric nodal marginal zone lymphoma in a Japanese boy","volume":"59","author":"Hori","year":"2017","journal-title":"Pediatr Int"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/DAD.0000000000000062","article-title":"Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"10.1016\/j.beha.2023.101440_bib51","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/pbc.26048","article-title":"Successful curative therapy with rituximab and allogeneic haematopoietic stem cell transplantation for MALT lymphoma associated with STK4-mutated CD4+ lymphocytopenia","volume":"63","author":"Lum","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjh.14868","article-title":"Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma","volume":"182","author":"Makarova","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10024-003-3025-6","article-title":"MALT lymphoma in children: case report and review of the literature","volume":"7","author":"Mo","year":"2004","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"10.1016\/j.beha.2023.101440_bib54","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2010.63","article-title":"Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR","volume":"23","author":"Rizzo","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26932","article-title":"Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection","volume":"65","author":"Ronceray","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tripleo.2008.10.013","article-title":"Pediatric mucosa-associated lymphoid tissue (MALT) lymphoma of lip: a case report and literature review","volume":"107","author":"Ryu","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pde.14028","article-title":"Complete resolution of primary cutaneous marginal zone B-cell lymphoma on the cheek of a 7-year-old boy with intralesional triamcinolone and tincture of time","volume":"37","author":"Skaljic","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000478-200304000-00014","article-title":"Marginal zone B-cell lymphoma in children and young adults","volume":"27","author":"Taddesse-Heath","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPH.0000000000001321","article-title":"Mucosal-associated lymphoid tissue (MALT) lymphoma in association with pediatric primary sjogren syndrome: 2 cases and review","volume":"41","author":"Tesher","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2023.101440_bib61","article-title":"Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the lacrimal drainage system in two pediatric patients","author":"Ucgul","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib62","first-page":"79","article-title":"[MALT lymphoma of the conjunctiva in a 13-year old child--5-year relapse-free follow-up following antibiotic treatment]","volume":"233","author":"Hoh","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cup.12102","article-title":"Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager","volume":"40","author":"Ghatalia","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1684\/ejd.2010.0987","article-title":"Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab","volume":"20","author":"Park","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib65","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0046-8177(88)80287-9","article-title":"Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(88)80259-4","article-title":"Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib67","article-title":"Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy","volume":"8","author":"Perrone","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib68","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib69","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2013.09.004","article-title":"Marginal zone lymphomas and infectious agents","volume":"23","author":"Ferreri","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib71","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0889-8553(05)70132-1","article-title":"Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori","volume":"29","author":"Morgner","year":"2000","journal-title":"Gastroenterol Clin N Am"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10428190500285285","article-title":"Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency","volume":"47","author":"Aghamohammadi","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaapos.2017.10.016","article-title":"Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant","volume":"22","author":"Bata","year":"2018","journal-title":"J AAPOS"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clml.2017.09.012","article-title":"Extranodal marginal zone lymphoma of the central nervous system","volume":"18","author":"Ayanambakkam","year":"2018","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib76","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/pbc.25419","article-title":"A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease","volume":"62","author":"Mittal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.dld.2015.10.008","article-title":"Bone marrow involvement is rare in superficial gastric mucosa-associated lymphoid tissue lymphoma","volume":"48","author":"Park","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib79","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jclinpath-2013-201520","article-title":"Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings","volume":"67","author":"Sovani","year":"2014","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib80","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cam4.2732","article-title":"An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement","volume":"9","author":"Sunderland","year":"2020","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib81","first-page":"470","article-title":"Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection","volume":"90","author":"Traverse-Glehen","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101440_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-444-63849-6.00014-1","article-title":"Primary CNS lymphoma in HIV infection","volume":"152","author":"Brandsma","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"10.1016\/j.beha.2023.101440_bib83","first-page":"1287","article-title":"Epstein-Barr virus-associated primary central nervous system lymphoma in a child with the acquired immunodeficiency syndrome. A case report and review of the literature","volume":"121","author":"Rodriguez","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"10.1016\/j.beha.2023.101440_bib84","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1182\/bloodadvances.2019001062","article-title":"Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents","volume":"3","author":"Attarbaschi","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.beha.2023.101440_bib85","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pbc.20736","article-title":"A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation","volume":"47","author":"Abla","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib86","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3171\/jns.1988.68.6.0835","article-title":"Primary central nervous system lymphoma","volume":"68","author":"Hochberg","year":"1988","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.beha.2023.101440_bib87","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/01616412.2000.11740697","article-title":"Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients","volume":"22","author":"Murase","year":"2000","journal-title":"Neurol Res"},{"key":"10.1016\/j.beha.2023.101440_bib88","series-title":"World Health organization classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib89","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib90","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.beha.2023.101440_bib91","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","article-title":"Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites","volume":"96","author":"Riemersma","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib92","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","article-title":"The genomic and transcriptional landscape of primary central nervous system lymphoma","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.beha.2023.101440_bib93","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/bloodadvances.2021006018","article-title":"A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome","volume":"6","author":"Guney","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bjh.14073","article-title":"Trends in primary central nervous system lymphoma incidence and survival in the U.S","volume":"174","author":"Shiels","year":"2016","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2023.101440_bib95","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/1078-0432.CCR-10-1161","article-title":"Primary CNS lymphoma in children and adolescents: a descriptive analysis from the international primary CNS lymphoma collaborative group (IPCG)","volume":"17","author":"Abla","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib96","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.3324\/haematol.2014.109553","article-title":"Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Munster protocols for systemic lymphoma","volume":"99","author":"Thorer","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib97","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3346\/jkms.2012.27.11.1378","article-title":"Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience","volume":"27","author":"Yoon","year":"2012","journal-title":"J Kor Med Sci"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib98","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.13216","article-title":"Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group","volume":"168","author":"Kontny","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib99","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00277-016-2722-y","article-title":"Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases","volume":"95","author":"Mellgren","year":"2016","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bjd.13440","article-title":"Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome","volume":"172","author":"Oschlies","year":"2015","journal-title":"Br J Dermatol"},{"issue":"24","key":"10.1016\/j.beha.2023.101440_bib101","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.beha.2023.101440_bib102","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.beha.2023.101440_bib103","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2023.101440_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29285","article-title":"Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents","volume":"68","author":"Au-Yeung","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib105","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1097\/MPH.0000000000002364","article-title":"Management of peripheral T-cell lymphoma in children and adolescents including STAT 3 mutation hyper-IgE syndrome: one size does not fit all","volume":"44","author":"Ravichandran","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"25","key":"10.1016\/j.beha.2023.101440_bib106","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.beha.2023.101440_bib107","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"10168","key":"10.1016\/j.beha.2023.101440_bib108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib109","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.annonc.2021.12.002","article-title":"The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","volume":"33","author":"Horwitz","year":"2022","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.beha.2023.101440_bib110","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1182\/bloodadvances.2020003971","article-title":"Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2","volume":"6","author":"Savage","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.beha.2023.101440_bib111","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bjh.15767","article-title":"Mature (non-anaplastic, non-cutaneous) T-\/NK-cell lymphomas in children, adolescents and young adults: state of the science","volume":"185","author":"Flower","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib112","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/bjh.15772","article-title":"Treatment and prognosis of mature (non-anaplastic) T- and NK-cell lymphomas in childhood, adolescents, and young adults","volume":"185","author":"Xavier","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.beha.2023.101440_bib113","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib114","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.2007.06835.x","article-title":"Progress in understanding and managing natural killer-cell malignancies","volume":"139","author":"Oshimi","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.beha.2023.101440_bib116","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Ito","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.beha.2023.101440_bib117","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-018-0324-5","article-title":"Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma","volume":"33","author":"Peng","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101440_bib118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fonc.2019.00386","article-title":"Epstein-barr virus-positive natural killer\/T-cell lymphoma","volume":"9","author":"Cai","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.beha.2023.101440_bib119","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0145-2126(94)90025-6","article-title":"Clinical relevance of P-glycoprotein expression in haematological malignancies","volume":"18","author":"Nooter","year":"1994","journal-title":"Leuk Res"},{"issue":"14","key":"10.1016\/j.beha.2023.101440_bib120","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1080\/10428194.2020.1811864","article-title":"Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population","volume":"61","author":"Ghione","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","article-title":"Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan","volume":"35","author":"Yamaguchi","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.beha.2023.101440_bib122","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00277-015-2395-y","article-title":"Radiotherapy and PGEMOX\/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK\/T-cell lymphoma","volume":"94","author":"Bi","year":"2015","journal-title":"Ann Hematol"},{"issue":"17","key":"10.1016\/j.beha.2023.101440_bib123","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2023.101440_bib124","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-017-3127-2","article-title":"PD1 blockade with low-dose nivolumab in NK\/T cell lymphoma failing L-asparaginase: efficacy and safety","volume":"97","author":"Chan","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2023.101440_bib125","article-title":"Efficacy and safety of PD-1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer\/T cell lymphoma: a retrospective study","author":"Tian","year":"2022","journal-title":"Hematol Oncol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:07:30Z","timestamp":1761498450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692623000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521692623000014"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2023.101440","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of rare paediatric Non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2023.101440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101440"}}